Maharashtra Herald

Exosome Diagnostics and Therapeutic Market Size Worth $ 358.91 Million by 2027 – The Insight Partners

 Breaking News
  • No posts were found

Exosome Diagnostics and Therapeutic Market Size Worth $ 358.91 Million by 2027 – The Insight Partners

November 24
21:44 2021
Exosome Diagnostics and Therapeutic Market Size Worth $ 358.91 Million by 2027 - The Insight Partners
The exosome diagnostic and therapeutic market is expected to grow owing to factors such as greater precision and advantages over traditional methods of diagnosis and therapeutics and increasing number of research activities in the field of exosomes.

According to The Insight Partners market research study of “Exosome Diagnostic and Therapeutic Market Forecast to 2027 – Covid-19 Impact and Global Analysis by Application, Product, and End User,” the global exosome diagnostic and therapeutic market is projected to reach US$ 358.91 million by2027 from US$ 41.6.33 million in2019. The market is estimated to grow at a CAGR of 32.2% from 2020 to 2027. The report highlights trends prevailing in the global exosome diagnostic and therapeutic market and the factors driving market along with those that act as hindrances.

Strategic Insights:

Report Coverage             


Market Size Value in      

(US$ 41.6.33 million in 2019)

Market Size Value by    

(US$ 358.91 million 2027)

Growth Rate     

(CAGR of 32.2% from 2020 to 2027)

Forecast Period

(2020- 2027)

Base Year           


No. of Pages     


No. Tables          


Segments covered         

(By Product, Service Application, End User)

Regional scope 

(North America; Europe; Asia Pacific; Latin America; MEA)

Country scope  

(US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina)

Report coverage             

(Revenue forecast, company ranking, competitive landscape, growth factors, and trends)

Get Sample PDF Copy of Exosome Diagnostics and Therapeutic Market at:

Exosomes are nano-vesicles that constitute proteins, DNA, and RNA. Exosomes play an important role in aiding cell-to-cell communication while diagnosing cancer. It lowers the body’s immune function by stimulating programmed cell death of activated cytotoxic T-cells, which modify neoplasm progression within the human body. The exosome diagnostic and therapeutic market is expected to witness huge growth due to greater precision and advantages over traditional methods of diagnosis and therapeutics. However, poor infrastructure and lack of expertise required for isolation of exosomes may hinder the market growth.

Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics

Exosomes are distinct populations of tiny membranous vesicles, released into the extracellular space by most cells, which get eventually accumulated in the body fluid circulation. By acting as cellular messengers, they play a role in vital physiological functions by transporting information between different cell types. These tiny particles carry cellular nucleic acids and proteins from their host cells to target cells, which represent the comprehensive information about pathophysiological conditions of the host cell. For instance, exosomes released from tumor cells contains tumor-specific RNAs that can be potentially detected during cancer diagnosis. These carrier exosomes can also be used as biomarkers in the diagnosis of neurodegenerative and metabolic disorders, and infectious and other diseases. Additionally, the presence of exosomes in body fluids such as saliva and urine islikely to rule out the traditional methods involving the collection of the invasive body fluids.Thus, the growing emphasis on clinically noninvasive diagnosis is likely to drive the adoption of exosomes-based diagnosis and therapeutics in the medical industry during the forecast period.

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns.

Download the Latest COVID-19 Analysis on Exosome Diagnostics and Therapeutic Market Growth Research Report at:

Based on application, the exosome diagnostic and therapeutic market is further segmented into diagnostic applications and therapeutic applications. The diagnostic applications segment held a larger share of the market in 2019owing to increasing awareness of the procedural outcomes served by exosomes.

The exosome diagnostic and therapeuticmarket, by product, is sub segmented into instruments, reagents, and software.In 2019, the instrument segment accounted for the largest share of the global exosome diagnostic and therapeuticmarket owing to increasing adoption of instruments for diagnostic applications. However, the software segment is estimated to register the highest CAGR in the market during the forecast period. This can be attributed to the demand for technological platforms offering data integrity, access, and security for collected data in exosome diagnostic and therapeutic applications.

Exosome Diagnostics and Therapeutic Market: Competitive Landscape and Key Developments

Leading companies operating in the exosome diagnostic and therapeutic market are Aethlon Medical, Inc., Therapeutic Solutions International, Inc., ReNeuron Group plc, Immune Therapy Holdings AB, Cell Guidance Systems LLC, BioRegenerative Sciences, Evomic Science LLC, NorgenBiotek Corp., Exosome Diagnostics, Inc./Bio-Techne, and MiltenyiBiotec, among others.

Order a Copy of Exosome Diagnostics and Therapeutic Market Shares, Strategies and Forecasts 2021-2028 Research Report at:

For instance, in March 2016, Sysmex and JVCKENWOOD launched a joint program for the development of diagnostic instruments for measurement of exosomes. Also, the diagnostic segment is expected to register ahigher CAGR in the market during the forecast period. Apart from this, exosomes are emerging as promising therapeutic platforms due to its role in disease prorogation. Such involvement of exosomes can allow us to inhibit the disease progression with the help of targeted drug therapy.

Product launches and expansion strategy is commonly adopted by companies to expand their footprint worldwide and meet the growing demand. This strategy is most commonly adopted by the market players in order to expand its product portfolio.

Browse Related Reports and get Sample copy

Exosome Research Products Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Kits and Reagents, Instruments and Services); Application (Cancer Application, Non-Cancer Application,); End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies and Hospitals and Clinical Testing Laboratories)

Exosomes Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product and Service (Kits and Reagents, Instruments, Services); Type (Non-Coding RNAs, mRNA, Proteins, DNA Fragments, Lipids, Others); Application (Cancer, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Others), and Geography 

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Research Study –

Media Contact
Company Name: The Insight Partners
Contact Person: Sameer Joshi
Email: Send Email
Phone: +1-646-491-9876
City: Pune
State: Maharashtra
Country: India